Research Interest: Maternal fetal medicine,Prenatal diagnosis,Intrauterine growth restrictions and cardiovascular changes,Fetal echocardiography,Fetal programming,Fetal anemia,Preterm deliveries.

Dr. Mohammad E. Barbati, MD received his medical degree at Shahid Beheshti University of Medical Science, Iran in 2008. From 2008 to 2012 he worked as the transplant coordinator in Organ Transplantation Center of Shahid Beheshti University. He continued his medical study with residency in vascular and endovascular surgery at the University of Aachen and obtained his board license in 2018. Dr. Barbati performs all aspects of vascular and endovascular surgery including complex chronic venous obstructive disease.

Research Interest: Venous diseases and treatments

Research Interest: Vascular Medicine and Endothelial Stem Cell Regulation

Research Interest: Minimal invasive techniques for advanced coronary, peripheral and vascular interventions, Stem cell therapy for heart failure, Use of Biodegradable filters for DVT and PE, Development of catheters and devices for transcatheter aortic valve replacements.

Dr. Qiu, Sheng-Xiang is a Professor and the Director of the Natural Product Chemical Biology & Drug Discovery Program of South China Botanical Garden of Chinese Academy of Sciences. He completed his undergraduate and M. S. degrees in China and received his PhD from University of Illinois at Chicago in the United States. Dr. Qiu led a research team to discover bioactive natural products from plants for the treatment of infectious diseases, immune disorders, cancer, diabetes, and hyperuricemia. His team applies advanced molecular and cell biology technologies, computational chemistry, and network pharmacology to decipher the mechanism of action of the active compounds from plants to tackle key issues in natural product-based drug discovery. After decades of hard work, Qiu’s team has made several groundbreaking achievements. They discovered that several xanthones in mangosteem and phloroglucinols in myrtle are novel antimicrobial agents against methicillin-resistant bacteria. They identified plant Pinosylvin monomethyl ether possessed strong antifungal activity against pathogenic fungi associated with aflatoxin B1 accumulation, likely a cause of the high incidence of liver cancer in China. They discovered Rhodomyrtone as the first plant-derived broad-spectrum antiviral chemical against SARS-CoV-2 by modulating host defense. They identified a stilbenoid as the first anti-HPV natural small molecule with dual function of blocking HPV infection and reversing HPV-induced cancerous transformation of cervical cells. Cajaninstilbene acid from pigeon pea was identified to be the first plant-derived AhR agonist with the potential to treat psoriasis. Dr. Qiu has published >200 papers in peer-reviewed journals and holds >30 patents.

Research Interest: Natural product medicinal Chemistry/chemical biology; Pharmacology; signaling transduction; Drug discovery.

Research Interest: Myocardial infarction, aortic dissection and aortic aneurysm.

Research Interest: Aortic surgery, Totally arterial myocardial revascularization, Ecmo (San Gerardo cardiac ECMO program coordinator, ELSO Registry membership), Mitral valve repair, Minimized extracorporeal circulation (MECC).